ACVR2A

There are 22 papers on ACVR2A in aging research: 1 trial and 2 observational studies in people, 7 in animals, 2 in cells, 9 reviews. The newest story, Nov 7, 2026: “Blocking activin signals improved heart filling in mice”.

Gene

22 papers study it3 findings

HGNCNCBI GeneTaxon

2 new papers in 30 daysSee all 22 papers on ACVR2A

At a glance

The findings reach mice, none yet in people. 2 independent labs in 2 countries; 4 trials, 1 with no results posted.

None of its findings points the other way.

Cells and mice: a single group. Worms or flies and humans: nothing yet.
  • 2 independent labs in 2 countries
  • 4 trials, 1 with no results posted
  • Funders: American Heart Association and others
  • 3 of 4 trials sponsored by developers of drugs aimed at it
  • Human trial1
  • Humans2
  • Animals7
  • Cells2
  • In silico1

Effects

3

Open cardiac lymphatic vessels

downin mice1

1 study
  1. ACVR2A decreases open cardiac lymphatic vessels in mice (shown by endothelial deletion in doxorubicin-treated mice).

    “endothelial Acvr2a deletion in aged doxorubicin-treated mice was associated with improved cardiac function and increased open cardiac lymphatic vessels”

    Animalsshown by endothelial deletion in doxorubicin-treated micecardiac lymphatic vessels

    Physiological Aging and Cardiovascular Disease Distinctly Remodel the Human Cardiac Lymphatic Endothelium

    bioRxivPreprint

Cardiac function

downin mice1

1 study
  1. ACVR2A impairs cardiac function in mice (shown by endothelial deletion in doxorubicin-treated mice).

    “endothelial Acvr2a deletion in aged doxorubicin-treated mice was associated with improved cardiac function and increased open cardiac lymphatic vessels”

    Animalsshown by endothelial deletion in doxorubicin-treated mice

    Physiological Aging and Cardiovascular Disease Distinctly Remodel the Human Cardiac Lymphatic Endothelium

    bioRxivPreprint

Telomere elongation

downin mouse cells1

1 study
  1. ACVR2A decreases telomere elongation in mouse cells (shown by knockdown).

    “Downregulation of Acvr2a promoted telomere elongation and pluripotency.”

    Cellsshown by knockdown

    The miR-590/Acvr2a/Terf1 Axis Regulates Telomere Elongation and Pluripotency of Mouse iPSCs

    Stem cell reports

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 2May 2026: 0Jun 2026: 2Jul 2026: 0Aug 2026: 0Sep 2026: 2Oct 2026: 0Nov 2026: 28 papers in 12 months
AHA Scientific Sessions 2026 Abstract

Blocking activin signals improved heart filling in mice

Removing two activin receptor types from certain immune cells lowered a heart-filling pressure index to 31.93, versus 42.99 in heart-failure mice.Removing two activin receptor types from certain immune cells lowered a heart-filling pressure index to 31.93, versus 42.99 in heart-failure mice.

Mouse studyMechanisms

See all 22 papers on ACVR2A